Literature DB >> 33545866

3D bioprinting of a stem cell-laden, multi-material tubular composite: An approach for spinal cord repair.

Omar A Hamid1, Hoda M Eltaher2, Virginie Sottile3, Jing Yang4.   

Abstract

Development of a biomimetic tubular scaffold capable of recreating developmental neurogenesis using pluripotent stem cells offers a novel strategy for the repair of spinal cord tissues. Recent advances in 3D printing technology have facilitated biofabrication of complex biomimetic environments by precisely controlling the 3D arrangement of various acellular and cellular components (biomaterials, cells and growth factors). Here, we present a 3D printing method to fabricate a complex, patterned and embryoid body (EB)-laden tubular scaffold composed of polycaprolactone (PCL) and hydrogel (alginate or gelatine methacrylate (GelMA)). Our results revealed 3D printing of a strong, macro-porous PCL/hydrogel tubular scaffold with a high capacity to control the porosity of the PCL scaffold, wherein the maximum porosity in the PCL wall was 15%. The method was equally employed to create spatiotemporal protein concentration within the scaffold, demonstrating its ability to generate linear and opposite gradients of model molecules (fluorescein isothiocyanate-conjugated bovine serum albumin (FITC-BSA) and rhodamine). 3D bioprinting of EBs-laden GelMA was introduced as a novel 3D printing strategy to incorporate EBs in a hydrogel matrix. Cell viability and proliferation were measured post-printing. Following the bioprinting of EBs-laden 5% GelMA hydrogel, neural differentiation of EBs was induced using 1 μM retinoic acid (RA). The differentiated EBs contained βIII-tubulin positive neurons displaying axonal extensions and cells migration. Finally, 3D bioprinting of EBs-laden PCL/GelMA tubular scaffold successfully supported EBs neural differentiation and patterning in response to co-printing with 1 μM RA. 3D printing of a complex heterogeneous tubular scaffold that can encapsulate EBs, spatially controlled protein concentration and promote neuronal patterning will help in developing more biomimetic scaffolds capable of replicating the neural patterning which occurs during neural tube development.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D printing; Embryoid body (EB); Gradient; Hydrogels; Nerve regeneration; Neural differentiation; Polycaprolactone

Mesh:

Substances:

Year:  2020        PMID: 33545866     DOI: 10.1016/j.msec.2020.111707

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

Review 1.  Smart/stimuli-responsive hydrogels: Cutting-edge platforms for tissue engineering and other biomedical applications.

Authors:  Hussein M El-Husseiny; Eman A Mady; Lina Hamabe; Amira Abugomaa; Kazumi Shimada; Tomohiko Yoshida; Takashi Tanaka; Aimi Yokoi; Mohamed Elbadawy; Ryou Tanaka
Journal:  Mater Today Bio       Date:  2021-12-09

2.  Towards 3D Bioprinted Spinal Cord Organoids.

Authors:  Yilin Han; Marianne King; Evgenii Tikhomirov; Povilas Barasa; Cleide Dos Santos Souza; Jonas Lindh; Daiva Baltriukiene; Laura Ferraiuolo; Mimoun Azzouz; Maurizio R Gullo; Elena N Kozlova
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

3.  Application of Machine Learning in 3D Bioprinting: Focus on Development of Big Data and Digital Twin.

Authors:  Jia An; Chee Kai Chua; Vladimir Mironov
Journal:  Int J Bioprint       Date:  2021-01-29

4.  An open source extrusion bioprinter based on the E3D motion system and tool changer to enable FRESH and multimaterial bioprinting.

Authors:  Adam Engberg; Christina Stelzl; Olle Eriksson; Paul O'Callaghan; Johan Kreuger
Journal:  Sci Rep       Date:  2021-11-03       Impact factor: 4.379

Review 5.  The 3D Bioprinted Scaffolds for Wound Healing.

Authors:  Pablo Edmundo Antezana; Sofia Municoy; María Inés Álvarez-Echazú; Pablo Luis Santo-Orihuela; Paolo Nicolás Catalano; Taleb H Al-Tel; Firoz Babu Kadumudi; Alireza Dolatshahi-Pirouz; Gorka Orive; Martin Federico Desimone
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.